Tag: obesity

Study Links Ozempic To Blindness, Adding To Growing List Of Side Effects

Diabetes patients who took Ozempic were more than twice as likely to develop an eye condition that causes vision loss than patients using a different diabetes drug, according to a new study.

The study linked semaglutide, the active ingredient in Ozempic and Wegovy — which in addition to treating diabetes are widely used to lose weight — to non-arteritic anterior ischemic optic neuropathy (NAION).

The study, published last week on a preprint server, is undergoing peer review.

NAION can result in sudden vision loss due to loss of blood flow to the optic nerve. It is a major cause of severe vision loss and blindness in adults and the second-most common form of optic nerve damage after glaucoma. There is no effective treatment for the condition.

Doctors have recommended that patients considering taking these drugs should be informed of the risk, Bloomberg reported.

While the absolute risk of the disorder remains low, the authors of the study said, they found 1.4 additional cases per 10,000 among patients who took Ozempic.

Researchers analyzed data from the national healthcare registries in Denmark and Norway, comparing the rates of NAION between people taking semaglutide (Ozempic) versus those taking SGLT-2s, an older class of drugs used to treat Type 2 diabetes.

Keep reading

Weight-loss Drug Prescriptions for Kids and Teens Soar Despite No Safety Data

The number of weight-loss drug prescriptions provided by pediatric and adolescent medical specialists for children and teens increased sevenfold between October 2022 and September 2024, according to a MedPage Today analysis of Symphony, a prescription drug database.

Prescriptions for Novo Nordisk’s drugs liraglutide, the generic name for Saxenda, and semaglutide, the generic name for Wegovy and Ozempic, rose from 3,448 to 24,435 in the U.S. during that time.

Total prescriptions for all GLP-1 receptor agonist drugs — the broader class of drugs they are part of — prescribed by pediatric and adolescent medicine specialists, more than doubled during the same period, from 59,868 to 125,538.

However, those numbers do not even include GLP-1 drugs prescribed to children by primary care physicians or family medicine practitioners, or at compounding pharmacies, MedPage Today said.

Since the U.S. Food and Drug Administration (FDA) approved Wegovy in 2021, the drug — and the entire class of drugs — has become a sensation, promoted by influencers and celebrities, helping to fuel a massive new drug market estimated to be worth $100 billion a year for drugmakers.

About 20% of U.S. children and adolescents are chronically obese, according to the Centers for Disease Control and Prevention (CDC). The FDA approved Saxenda to treat obesity in kids 12 and up in December 2020 and Wegovy in December 2022.

Keep reading

Harvard Study: Half of Adult Americans Eligible for Ozempic-Like Drugs

Glucagon-like peptide receptor agonists (GLP-1 RA) are the current financial rainmakers for BIG PHARMA.

Shi et al from Harvard reported recently in JAMA Cardiology.

Rapidly increasing uptake of semaglutide made it the top-selling drug in the US in 2023, with net sales of $13.8 billion. Quantifying the number of US adults eligible for semaglutide may guide future policies for this high-cost therapy and clarify potential implications for pharmaceutical spending.

The authors conclude that approximately 137 million adults or half the of the US population could have a clinical indication for once weekly GLP-1 RA drugs. This budget breaking conclusion no doubt will have to be addressed by the incoming HHS administration led by Robert F. Kennedy, Jr.

Keep reading

If Common Chemicals Harm Frogs and Rats, What Are They Doing to Your Children?

The TED Talk below features Penelope Jagessar Chaffer, director of the documentary film “Toxic Baby,” and Tyrone Hayes, Ph.D., a professor of integrative biology at the University of California, who has dedicated most of his career to studying the health effects of the herbicide atrazine.

According to Chaffer, the average American woman today has 30,000 to 50,000 chemicals in her body that her grandparents did not have. Many of these chemicals have been linked to the rapidly rising incidence of chronic childhood diseases.

In her talk, Chaffer cites the following statistics, which are likely higher today, since this talk was given in 2010:

  • In the United Kingdom (U.K.), the incidence of childhood leukemia rose by 20% in one generation.
  • In Canada, the prevalence of asthma increased by 400% in 20 years; 1 in 10 children is now diagnosed with asthma.
  • In the U.S., childhood cancers have seen a similar rise as that of childhood leukemia in the U.K. Autism spectrum disorder has also increased by 600% in the past 20 years; the incidence of autism rose by 57% between 2002 and 2006 alone.
  • In the Netherlands, Rotterdam has seen a 400% increase in genital birth defects.

Obesity and juvenile diabetes have also skyrocketed, and while a high-sugar diet likely bears the brunt of the blame, there’s every reason to suspect that endocrine-disrupting chemicals (EDCs) — many of which enter our system via processed foods — add to the metabolic dysfunction we now see.

Keep reading

The Biggest Drug Fraud in History

  • Ozempic, a diabetes drug now used for weight loss, is part of a massive fraud that could harm millions, especially children, by treating obesity without addressing its root causes.
  • The obesity epidemic is driven in part by ultra-processed foods designed to override natural satiety mechanisms, not by a lack of weight loss drugs like Ozempic.
  • The Treat and Reduce Obesity Act could mandate government coverage for obesity medications for 74% of Americans, costing over $3 trillion annually without addressing underlying health issues.
  • Ozempic’s maker, Novo Nordisk, has become a top lobbying spender in the U.S., pushing for expanded drug coverage while downplaying significant side effects like muscle loss, suicidal thoughts and increased cancer risk.
  • Naturally increasing GLP-1 levels through gut bacteria like Akkermansia muciniphila offers an alternative to Ozempic, promoting overall gut health without the risks associated with long-term pharmaceutical use.

The rise of Ozempic and similar drugs for weight loss involves fraud of unprecedented scale that could have devastating consequences for millions of Americans, especially children.

Ozempic, a drug initially developed for diabetes, has become a sensation for weight loss. Its popularity has skyrocketed, with everyone from celebrities to college students clamoring for prescriptions — but at what cost?

The active ingredient in Ozempic is part of a class of drugs called glucagon-like peptide-1 (GLP-1) agonists.

These drugs stimulate hormones in your digestive system that signal fullness. While this makes it easier for people to eat less and lose weight, the reality is far more complex and concerning.

Keep reading

The Great Ozempic Hustle

Most of the food in America comes from just a few crops like corn, wheat, soy, and canola, largely due to farming subsidies that force farmers to mass-produce these crops and sell them below cost. These cheap crops are then turned into the processed foods we eat every day. This is problematic because:

Health Issues: These foods are unhealthy and contribute to major health problems like diabetes and obesity.

Natural Aversion: Our bodies naturally resist these foods, making them hard to sell.

Addictive Additives: To make them more appealing, addictive substances are added. In the 1980s, Big Tobacco bought the processed food industry and, much like they did with cigarettes, focused on making these foods as addictive as possible.

Chronic Illness: The resulting health issues create lifelong customers for industries like Big Pharma.

For years, activists like Dr. Mercola have pushed for awareness of the importance of natural foods and the need to change farming subsidies to promote healthy eating. The current media climate, driven by skepticism of the COVID-19 response and the rise of independent media, has revealed the systematic failures in our food supply and allowed these long-cultivated ideas to begin bursting into public awareness.

For example, a few weeks ago, shortly after gaining the national spotlight and the need to make America Healthy Again by freeing us from pervasive regulatory corruption, RFK Jr. was invited onto Fox News to discuss the dangers of seed oils and artificial food colorings with a supportive newscaster—something I’d never before seen in the national media.

Keep reading

Days After RFK Jr. Signaled Desire to ‘Make America Healthy Again,’ Time Defends Ultra-Processed Foods + More

Time magazine ran a piece Monday questioning whether food linked to a litany of illnesses is really so bad.

Robert F. Kennedy Jr. revealed on Aug. 23 that a major factor behind his decision to endorse President Donald Trump was the opportunity to help “Make America Healthy Again” in a future Trump administration.

“Don’t you want healthy children?” said Kennedy. “And don’t you want the chemicals out of our food? And don’t you want the regulatory agencies to be free from corporate corruption? And that’s what President Trump told me that he wanted.”

Days later, Time magazine signaled a possible narrative shift regarding American health with an article titled “What if Ultra-Processed Foods Aren’t as Bad as You Think?” — having just months earlier published an article entitled “Why Ultra-Processed Foods Are So Bad for You.”

Kennedy, unwilling to buy what Time appeared to be selling, tweeted, “Yeah, what if? And what if ultra-processed foods are WORSE than you think?”

Keep reading

Arts Schools Offered “Plus-Size Inclusivity Training” to Tackle “Fatphobia”

The theatre industry and drama schools are embracing “plus-size inclusivity training” to combat “fatphobia” and promote a more ‘inclusive’ environment for fat people. The Telegraph has the details.

Ruth Anna Phillips, a “plus-size director” who runs workshops to address “anti-fat bias”, told the Stage earlier this month that “one drama school had already agreed to provide the size inclusion training for its staff.”

The training was devised “following research carried out by Ms. Phillips, which she said showed that nine out of 10 respondents felt teachers and facilitators should have training on size inclusion”, according to the weekly theatre newspaper.

Ms. Phillips is co-founder of Inclusion Collective, an organisation that provides training in “creative wellbeing”, “body positivity” and “inclusive movement”, among other areas. Her website contains resources on “fat activism” – “advocacy for the rights and dignity of fat people, combating discrimination” and “the body consciousness scale”, among other materials.

Phillips said she has been “able to solidify and archive her work” thanks to Arts Council England’s (ACE) “developing your creative practice grant” (DYCP), funded by the National Lottery.

Keep reading

Woke Culture Declares War on Beauty: Morbidly Obese Female Wins Miss Alabama and a MAN Wins Miss Maryland USA

The despicable woke left continued its unrelenting war on American society by declaring two hideous-looking individuals beauty pageant winners, one of whom is male.

As WKRG reported, 23-year-old Atmore resident Sara Milliken won Miss Alabama on her third try over Memorial Day weekend.

She claimed her goal was only to make the top 10 after failing to place in her previous two attempts.

“Just making it to top 10 was my goal, ya know, I could leave the weekend saying I was better than I was the year before, and it’s all about bettering yourself for me,” Milliken told WKRG.

But Milliken would have been laughed right out of the room in an actual beauty competition. WKRG-TV Digital Reporter Summer Poole posed for a picture with Milliken following her asinine victory in the pageant.

Who do you think looks more worthy of the crown?

Keep reading

VENOM NATION: Shocking Number of Americans Have Tried Gila Monster Venom-Based Weight Loss Drugs

A new poll reveals that a shocking percentage of Americans are taking risky Gila monster venom-based weight loss drugs.

According to the latest KFF Health Tracking Poll, one out of every eight adults in the U.S. has used one of the trendy GLP-1 agonist weight loss and diabetes drugs, such as Ozempic and Wegovy.

This class of drugs is based on compounds in the venom of Gila monsters, a type of small Southwestern lizard that happens to be the only venomous type of lizard found in America. Researchers discovered in the early 1990s that they have a special hormone in their venom that can control hunger and slow digestion.

GLP-1 agonists work by imitating a hormone known as GLP-1 that is naturally produced by the body and secreted from the small intestine to trigger the release of insulin while slowing stomach emptying and blocking glucagon secretion. It can also help people feel fuller after eating by impacting the parts of the brain responsible for processing satiety and hunger signals.

The poll found that roughly 6% of all American adults are currently taking one of these medications, which amounts to 15 million people.

Keep reading